North America Cold Sore Treatment Market is growing with factors such as rising prevalence of cold sore infection and increasing awareness about sexually transmitted diseases. Availability of generic drugs also acts as a major factor for the growth of the market. Rising rate of HSV infection among women and strategic initiatives by market players have also given a boom to the North America cold sore treatment market.
Increasing disposable income in the region has also propelled the growth of the market. However, patent termination of marketed drugs and risks of other diseases associated with cold sore are restraining the market growth.
North America Cold Sore Treatment Market Scenario
According to Data Bridge Market Research, the market for cold sore treatment in North America is dominated by GlaxoSmithKline plc., which accounts for an estimated market share of approximately 23% in the North America market. The company has gained outstanding sales by providing novel cold sore treatment drugs.
For instance,
- In June 2010, GlaxoSmithKline plc declared an agreement with Medivir for commercialization of Xerclear for OTC in global markets. Xerclear is the only topical herpes treatment clinically proven to prevent the appearance of cold sore lesions. The initiative by the company had resulted in exclusive benefit to commercialize and deliver non-prescribed Xerclear across various markets. This resulted in brand recognition and enhancement in product portfolio and positive growth in the market.
Trends Impacting the Market
Now the question is which other regions GlaxoSmithKline plc., Ortho Dermatologics, and FOUNDATION CONSUMER HEALTHCARE are targeting? Data Bridge Market Research has forecast a large growth in U.S. cold sore treatment market and the market leaders targeting Canada and Mexico to be their next pocket revenue for 2021.
The North America cold sore treatment market is becoming more competitive with companies including GlaxoSmithKline plc., Ortho Dermatologics, and FOUNDATION CONSUMER HEALTHCARE. These are the top dominating companies in cold sore treatment market and have launched novel cold sore treatment drugs in the market. The data bridge market research new reports highlights the major growth factors and opportunities in the North America cold sore treatment market.
For more analysis on the North America cold sore treatment market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=north-america-cold-sore-treatment-market
New Market Developments
- In February 2020, Ortho Dermatologics announced the launch of first, non-reimbursed, prescription program in dermatology, telemedicine platform on dermatology.com in the U.S. This will help the patients to consult with physicians, doctors and order branded dermatology products available on the website. This will help the company to expand its business and make the product profile strong.
- In October 2020, FOUNDATION CONSUMER HEALTHCARE acquired seven brands from GSK Consumer Healthcare via its Foundation Consumer Brands Company, which is under common management of FOUNDATION CONSUMER HEALTHCARE. With this acquisition, the company is focusing on increasing its product portfolio and penetrating the OTC market.
Scope of the North America cold sore treatment market
North America cold sore treatment market is segmented on the basis of countries into U.S., Canada, and Mexico.
All country based analysis of the North America cold sore treatment market is further analyzed based on maximum granularity into further segmentation.
- On the basis of strain type, the North America cold sore treatment market is segmented into herpes simplex type-1 virus (HSV) and herpes simplex type-2 virus (HSV).
- On the basis by therapeutics, the North America cold sore treatment market is segmented into antiviral agents, analgesic agents, and others.
- On the basis of drug type, the North America cold sore treatment market is segmented into branded and generics.
- On the basis of dosage type, the North America cold sore treatment market is segmented into oral, topical, and others.
- On the basis of end user, the North America cold sore treatment market is segmented into hospitals, homecare, specialty clinics, and others.
- On the basis of distribution channel, the North America cold sore treatment market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
To know more about the study https://www.databridgemarketresearch.com/reports/north-america-cold-sore-treatment-market
Key Pointers Covered in North America cold sore treatment Market Industry Trends and Forecast to 2028
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
Key Market Competitors Covered in the Report
- Merix Pharmaceutical Corp.
- GlaxoSmithKline plc.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals, Inc., U.S.A. (a subsidiary of Glenmark Pharmaceutical Ltd.)
- Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
- Cipla Limited
- Ortho Dermatologics’ (a division of Bausch Health Companies Inc.)
- FOUNDATION CONSUMER HEALTHCARE
- Sqaurex
- Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
- Viatris Inc.
- Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma)
- Novartis AG
- Jubilant Cadista (a subsidiary of Jubilant Life Sciences Ltd.)
- Hikma Pharmaceuticals PLC
- Apotex Inc.
- HRA Pharma
Above are the key players covered in the report, to know about more and exhaustive list of cold sore treatment companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=north-america-cold-sore-treatment-market
Research Methodology: North America cold sore treatment Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Manufacturer, Oncologists, Healthcare Industry, Scientists, Research Laboratories
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
- Europe Cold Sore Treatment Market – Industry Trends and Forecast to 2028
- Global Cold Sore Treatment Market – Industry Trends and Forecast to 2028
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
